RT Journal Article
SR Electronic
A1 Helwick, Caroline
T1 Comparison of Prasugrel and Clopidogrel for Patients Undergoing PCI for ACS
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 7
SP 10
OP 11
DO 10.1177/155989770700700703
UL http://mdc.sagepub.com/content/7/7/10.abstract
AB More potent antiplatelet therapy with prasugrel reduced the rate of ischemic events compared with clopidogrel among patients with acute coronary syndromes with planned percutaneous coronary intervention (PCI). The TRITON-TIMI 38 Trial showed that patients treated with the novel thienopyridine prasugrel had a significant net clinical benefit compared with clopidogrel, the standard therapy for patients undergoing PCI.